Rodatristat Ethyl Decreases Activity in Pulmonary Arterial Hypertension: Results from the ELEVATE-2 Trial
{{output}}
Rationale: Wearable devices provide an objective measurement of activity in the home setting and are complementary to 6-minute walk distance. Pulmonary arterial hypertension (PAH) patients have low daily activity time which is li... ...